Sensorium Therapeutics

Boston, MA · Founded 2021 · Privately Held (backing)

Developer of a therapeutic discovery platform designed to identify compounds for treating brain and mental health conditions. Sensorium Therapeutics is based in Boston, MA and was founded in 2021. Its last reported valuation was $47 million in Sep 2022. It has raised $69.7 million across 3 recorded rounds; the latest was a $26.8 million early-stage round in Jan 2025.

Last reported valuation
$47.0M
Oct 2026
Priced at
—
Total raised
$69.7M
Last round
Early Stage VC
Jan 2025

Who backs Sensorium Therapeutics?

16 investors
InvestorType
Service Provider CapitalVenture capital
Dolby Family VenturesVenture capital
Hatteras Venture PartnersVenture capital
Mission BioCapitalVenture capital
Ocama PartnersFamily office
Bonaventure Equity—
Bridge Builders Collaborative—
CU Healthcare Innovation Fund—
HB Investments—
Iter Investments—
+ 6 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Sensorium Therapeutics investors

16 investors are on record for Sensorium Therapeutics, including Service Provider Capital, Dolby Family Ventures, Hatteras Venture Partners and Mission BioCapital. By type, the record holds 4 venture capital firms and 1 family office. The early-stage round in Jan 2025 drew 19 investors.

Free account
More of Sensorium Therapeutics with a free account
  • ·The complete investor list: 16 names
  • ·Watch Sensorium Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 16 firms already write checks for companies like Sensorium Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View